TYRA (TYRA) Stock Price & Analysis
TYRA (TYRA) rose 15.24% to USD 28.65 as of September 8, 2026 at 05:01 UTC, according to Nexqual real-time market data.
TYRA last closed at USD 28.65; the session ranged USD 24.51–29.56 on volume of 1,864,601 shares. Market capitalization is —, with a 52-week range of USD 11.7–40.65 (NMS). Source: Nexqual, September 8, 2026 at 05:01 UTC.
Key Statistics (as of September 8, 2026 at 05:01 UTC)
| Price | USD 28.65 |
|---|---|
| Change | ▲ 15.24% (up) |
| Previous Close | USD 28.65 |
| Open | USD 28.65 |
| Day Range | USD 24.51 – 29.56 |
| 52-Week Range | USD 11.7 – 40.65 |
| Volume | 1,864,601 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (TYRA)
Nexqual's technical model rates TYRA "NEUTRAL" based on 3 bullish and 4 bearish signals across 128 daily candles, as of September 8, 2026 at 05:01 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 56.54 (neutral) |
| vs SMA50 | Below (USD 29.05) |
| MACD | -0.77 (negative) |
From TYRA's Latest SEC 10-K Filing (filed 2026-03-02)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | USD 43.07 | ▲ 2.6% |
| FDMT | 4D Molecular Therapeutics, Inc. | USD 14.97 | ▲ 0.2% |
| GLUE | Monte Rosa Therapeutics, Inc. | USD 13.84 | ▼ 2.67% |
| CGEM | Cullinan Therapeutics, Inc. | USD 22.09 | ▼ 1.07% |
| STOK | Stoke Therapeutics, Inc. | USD 29.81 | ▼ 2.26% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:01 UTC. This page is informational and not investment advice.